Prilosec 1 Labeling Studies Lead To Fall 2003 Launch Target

Procter & Gamble plans to introduce its nonprescription version of AstraZeneca's Prilosec (omeprazole) in the fall of 2003 based on the expectation it will obtain FDA approval for the switch in the year's third quarter